Kansas City, Mo.-based American Century has introduced five asset-allocation funds, named “Livestrong.” These funds are being marketed to boost the efforts of the Lance Armstrong Foundation, which supports those affected by cancer. In addition, it’s rolling out a line of “legacy” funds.

The Livestrong Portfolios 2015, 2025, 2035 and 2045 are target-date funds that are given more conservative allocations as the target date approaches. The Livestrong Income Portfolio aims to provide investors seeking current income with some growth potential via a fixed asset mix over time.

American Century, which has some $100 billion in assets under management, launched a series of asset-allocation funds, called My Retirement Portfolios, in August 2004. The latest funds will have the same fee structure and investment strategy, but they will not invest in tobacco companies.

Estimated expenses are:

FundTickerRATIO*

Livestrong IncomeARTOX0.77%

Livestrong 2015ARFIX0.82%

Livestrong 2025ARWIX0.87%

Livestrong 2035ARYIX0.92%

Livestrong 2045AROIX0.95%

Source: American Century

In February, American Century entered into a multi-year collaboration with cancer survivor and cyclist Lance Armstrong. American Century founder James Stowers Jr. is a cancer survivor; he established the Stowers Institute for Medical Research in 1994.

The company’s new line of “legacy” funds have been designed to reflect Stowers’ investment principles, with a focus on earnings and revenue growth and price momentum, according to Co-Portfolio Manager Harold Bradley. The new funds include: Legacy Large Cap (ACGOX), Legacy Focused Large Cap (ACFOX) and Legacy Multi Cap (ACMNX).

Janet Levaux is managing editor of Research.